Search
                    Washington Paid Clinical Trials
A listing of 1729  clinical trials  in Washington  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1537 - 1548 of 1729
        
                Washington is currently home to 1729 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Seattle, Spokane, Tacoma and Vancouver. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Consent for Use of Stored Patient Specimens for Future Testing
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                09/20/2024
            
            Locations: Univ of Washington, Seattle, Washington         
        
        
            Conditions: HIV Infections
        
            
        
    
                
                                    Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI
                                
            
            
        Recruiting
                            
            
                Spinal cord injury (SCI) can make it hard for the body to self-regulate some of its automatic functions like blood pressure, breathing, and heart rate. This can also make it hard for those living with SCI to exercise or complete their usual daily activities. The goal of this randomized trial is to test combinatory therapy of moderate arm-crank exercise paired with non-invasive transcutaneous spinal cord stimulation (tSCS) for cardiovascular recovery in adults aged 21-65 following chronic motor-c...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 21 years and 65 years
            Trial Updated:
                09/16/2024
            
            Locations: University of Washington, Seattle, Washington         
        
        
            Conditions: Spinal Cord Injuries
        
            
        
    
                
                                    Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
                                
            
            
        Recruiting
                            
            
                NUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors. The Phase 1 portion include patients with advanced solid tumors and is designed to determine the safety and the tolerability of doses of NUV-1511. In Phase 2, NUV-1511 will be given to determine the efficacy of patients with advanced solid tumors.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/13/2024
            
            Locations: Fred Hutchinson, Seattle, Washington         
        
        
            Conditions: Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC), Pancreatic Cancer, Platinum-resistant Ovarian Cancer (PROC)
        
            
        
    
                
                                    Single-Sided Deafness and Asymmetric Hearing Loss
                                
            
            
        Recruiting
                            
            
                The purpose of the study is to evaluate the long-term safety and effectiveness of cochlear implantation of the approved population in adults and children with single-sided deafness and asymmetric hearing loss.             
        
        
    Gender:
                ALL
            Ages:
                5 years and above
            Trial Updated:
                09/12/2024
            
            Locations: Virginia Mason Medical Center, Seattle, Washington         
        
        
            Conditions: Hearing Loss, Unilateral, Hearing Loss, Sensorineural
        
            
        
    
                
                                    Selinexor and Backbone Treatments of Multiple Myeloma Patients
                                
            
            
        Recruiting
                            
            
                This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of patients with relapsed/refractory multiple myeloma (RRMM) and newly diagnosed multiple myeloma (NDMM). The combinations to be evaluated are:
* Arm 1: Selinexor + dexamethasone + pomalidomide (SPd); enrollment complete
* Arm 2: Selinexor + dexamethasone + bortezomib (SVd); enrollment complete
* Arm 3: Selinexor + dexamethas...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/12/2024
            
            Locations: Swedish Cancer Institute, Seattle, Washington         
        
        
            Conditions: Multiple Myeloma
        
            
        
    
                
                                    Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
                                
            
            
        Recruiting
                            
            
                An investigator-initiated, prospective, consecutively enrolling, non-randomized single institution clinical evaluation of the safety and effectiveness of branched and fenestrated-branched endovascular stent grafts to preserve branch vessels when used in the treatment of patients with thoraco-abdominal aortic aneurysms. The study evaluates non-FDA-approved off the shelf and custom made branched and fenestrated-branched stent grafts manufactured by Cook Medical.
The primary objectives of this stu...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/12/2024
            
            Locations: University of Washington/Harborview Medical Center, Seattle, Washington         
        
        
            Conditions: Thoracoabdominal Aortic Aneurysm, Without Rupture
        
            
        
    
                
                                    Effectiveness of Remote Foot Temperature Monitoring
                                
            
            
        Recruiting
                            
            
                Diabetic foot ulcers are common, debilitating, and costly complications of diabetes, disproportionately impacting Black and rural Veterans. Forty percent of individuals have an ulcer recurrence within a year of ulcer healing and 65% within 5 years. Monitoring plantar foot temperatures is one of the few interventions that reduces the risk of ulcer recurrence. Despite the evidence, adoption has been poor because the original procedures, including the use of handheld thermometers, were burdensome a...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 89 years
            Trial Updated:
                09/11/2024
            
            Locations: VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington         
        
        
            Conditions: Diabetic Foot
        
            
        
    
                
                                    Pilot Trial of the RUBI Program for Autistic Adults
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to evaluate if a redesigned version of the RUBI parenting intervention can reduce challenging behaviors and improve adaptive skills in autistic adults with co-occurring challenging behaviors. The main questions it aims to answer are:
* Is the redesigned RUBI intervention feasible and acceptable for autistic adults and their families?
* Does the redesigned RUBI intervention reduce challenging behaviors and enhance the quality of life for autistic adults?
* Rese...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/09/2024
            
            Locations: Seattle Children's Autism Center, Seattle, Washington         
        
        
            Conditions: Autism Spectrum Disorder, Behavior, Parenting
        
            
        
    
                
                                    Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients
                                
            
            
        Recruiting
                            
            
                This is a Phase II trial to assess feasibility of pembrolizumab + INBRX-106 as a chemotherapy-sparing neoadjuvant therapy. One therapeutic arm is being evaluated to provide an informal comparison of pharmacodynamic and clinical effects of concurrent dosing schedule.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/09/2024
            
            Locations: Swedish Cancer Institute, Seattle, Washington         
        
        
            Conditions: Triple Negative Breast Cancer
        
            
        
    
                
                                    InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
                                
            
            
        Recruiting
                            
            
                The purpose of this randomized controlled trial is to evaluate whether the InMotion intervention, delivered via telehealth (using a HIPAA-compliant video platform or phone), which uses evidence-based behavioral and motivational counseling to increase daily physical activity, is an effective treatment for Major Depressive Disorder (MDD) for people who are at least one year out from sustaining a traumatic brain injury (TBI). The first aim is to compare the efficacy of the InMotion intervention to...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 64 years
            Trial Updated:
                09/09/2024
            
            Locations: University of Washington Medical Center, Seattle, Washington         
        
        
            Conditions: TBI (Traumatic Brain Injury), Depressive Disorder, Major, Clinical Depression, Mood Depressed, Physical Inactivity
        
            
        
    
                
                                    Glaucoma Evaluation With the P200TE
                                
            
            
        Recruiting
                            
            
                Images captured on the P200TE device on glaucoma patients             
        
        
    Gender:
                ALL
            Ages:
                22 years and above
            Trial Updated:
                09/05/2024
            
            Locations: Specialty Eyecare Centre, Bellevue, Washington         
        
        
            Conditions: Glaucoma
        
            
        
    
                
                                    Transcutaneous Stimulation for Neurological Populations
                                
            
            
        Recruiting
                            
            
                The purpose of the study is to evaluate whether non-invasive stimulation over the spinal cord at the neck and/or lower back can improve walking function for people with neurologic conditions. Spinal stimulation has been used extensively for individuals with spinal cord injury, and has demonstrated improvements in function. This study will extend this work to other neurologic conditions, such as cerebral palsy and stroke, that also demonstrate similar impairments as spinal cord injury.
The prima...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 4 years and 70 years
            Trial Updated:
                09/05/2024
            
            Locations: University of Washington, Seattle, Washington         
        
        
            Conditions: Neurological Disorder, Cerebral Palsy
        
            
        
    